Image

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

Join the ALLFTD study on Frontotemporal Lobar Degeneration!

Recruiting
18 years and older
All
Phase N/A
The ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) study is a research project that looks into a brain condition called *Frontotemporal Lobar Degeneration* (FTLD). This condition affects parts of the brain responsible for decision-making, behavior, and language. The study has two parts: a **longitudinal arm** and a **biofluid-focused arm**. The longitudinal arm involves yearly check-ups using different tests and scans, while the biofluid-focused arm mainly collects blood and other samples. Participants can be people with a family history of FTLD or those with symptoms, but no known family link. The study looks at different types of FTLD, including Progressive Supranuclear Palsy (affects movement), Primary Progressive Aphasia (affects language), and others. People with other health issues like Alzheimer's, brain tumors, or severe alcohol problems can't join the study. **Key Points:** - The study involves annual visits for comprehensive assessments. - Participants can be from families with FTLD history or have symptoms without family history. - Exclusions include other brain diseases or severe health conditions. For more information, visit ALLFTD website.
Study details
    Frontotemporal Lobar Degeneration (FTLD)
    Progressive Supranuclear Palsy (PSP)
    Corticobasal Degeneration (CBD)
    Behavioral Variant Frontotemporal Dementia (bvFTD)
    Semantic Variant Primary Progressive Aphasia (svPPA)
    Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
    FTD with Amyotrophic Lateral Sclerosis (FTD/ALS)
    Amyotrophic Lateral Sclerosis
    Oligosymptomatic PSP (oPSP)
    C9orf72
    GRN Related Frontotemporal Dementia
    MAPT Gene Mutation
    TBK1 Gene Mutation
    Oligosymptomatic Progressive Supranuclear Palsy

NCT04363684

Mayo Clinic

30 March 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.